| abstract |
The present disclosure relates to adenine analogs, methods of making adenine analogs, and methods of using such analogs to treat disorders associated with PINK1 kinase activity, including but not limited to neurodegenerative diseases, mitochondrial diseases, fibrosis, and/or cardiomyopathy. will be. This summary is intended as a scanning tool for searching in specific technical fields and is not intended to limit the present invention. |